307 participants
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-03
- Start Date:
- 2015-11-30
- Completion:
- 2021-02-19
Conditions
- Colorectal Carcinoma
Interventions
- DRUG
- BIOLOGICAL